Fagron NV engages in the development, marketing, and distribution of healthcare products and services. It operates through the following segments: Fagron Specialty Pharma Services (FSPS); Fagron Trademarks (FTM); Fagron Essentials (FE); and HL Technology. The FSPS segment refers to all personalized medication that is prepared in sterile and non-sterile compounding facilities in Europe, the United States, Colombia and South Africa. The FTM segment encompasses the innovative concepts, vehicles and formulations developed by Fagron, often in close cooperation with prescribers, pharmacies and universities. The FE segment relates to all pharmaceutical raw materials, equipment and supplies a pharmacist needs to prepare medication in its own pharmacy. The HL Technology segment is responsible for the development and production of precision components and orthopedic tools for the dental and medical industry. The company was founded in 1990 and is headquartered in Nazareth, Belgium.